Manufacturing method of cordyceps root securing promoting blood medicine

A production method and drug technology, applied in drug combinations, pharmaceutical formulas, medical preparations containing active ingredients, etc., can solve problems such as unsatisfactory efficacy of kidney transplantation, relieve renal vasospasm, and correct lipid metabolism disorders , Improve the effect of filtration rate

Inactive Publication Date: 2004-03-03
王保健
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Efficacy of kidney transplan

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Embodiment 1: Consists of the following combination components of A, B, C, and D, which respectively adopt the following components in parts by weight: Component A: Saffron 6, Cordyceps sinensis 8, Alisma 30, Salvia miltiorrhiza 23, Rhizoma Chuanxiong 3, Motherwort 32; B component: American ginseng 8, Cordyceps sinensis 7, Astragalus 45, Angelica 20, Banlangen 10, Dilong 5; C component: Astragalus 22, Panax notoginseng 8, Yinhua 15, Forsythia 17, Dodder 15, Chanyi 15 Component D: Gongying 27, Rhubarb 28, Smilax 22, Oyster 16. Grind the above three components A, B and C into powder respectively, pass through a 100-mesh sieve, and put them into capsules according to the weight ratio of 1:1:1. After decocting component D for 30 minutes, Take its juice and sterilize it at high temperature and seal it for later use.

Embodiment 2

[0023] Embodiment 2: Consists of the following combination components of A, B, C, and D, which respectively adopt the following components in parts by weight: Component A: Saffron 5, Cordyceps sinensis 10, Alisma 20, Salvia miltiorrhiza 28, Rhizoma Chuanxiong 8, Motherwort 28; B component: American ginseng 5, Cordyceps sinensis 9, Astragalus 38, Angelica 25, Banlangen 15, Dilong 8; C component: Astragalus 25, Panax notoginseng 5, Yinhua 18, Forsythia 22, Cuscuta 19, Chanyi 20 Component D: Gongying 31, Rhubarb 24, Smilax 29, Oyster 13. Grind the above three components A, B, and C into powder respectively, pass through an 80-mesh sieve, and put them into capsules according to the ratio of 1:1:1 by weight. After decocting component D for 30 minutes, Take its juice and sterilize it at high temperature and seal it for later use.

Embodiment 3

[0024] Embodiment 3: Consists of the following A, B, C, and D combination components, which respectively adopt the following components in parts by weight: Component A: Saffron 4, Cordyceps sinensis 12, Alisma 25, Salvia miltiorrhiza 35, Rhizoma Chuanxiong 5, Motherwort 24; B component: American ginseng 3, Cordyceps sinensis 13, Astragalus 30, Angelica 31, Banlangen 20, Dilong 12; C component: Astragalus 32, Panax notoginseng 3, Yinhua 23, Forsythia 12, Dodder 22, Chanyi 10 Component D: Gongying 36, Rhubarb 32, Smilax 33, Oyster 10. Grind the above three components A, B, and C into powder respectively, pass through a 90-mesh sieve, and put them into capsules according to the weight ratio of 1:1:1. After decocting component D for 30 minutes, Take its juice and sterilize it at high temperature and seal it for later use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A Chinese medicine for treating renal failure is prepared from 21 Chinese-medicinal materials, which is divided into 4 groups A, B C and D, including saffron, cordyceps, red sage root, American ginseng, etc through pulverizing groups A, B and C, proportional mixing and loading in capsules, decocting group D, high-temp stabilizing and sealing. Its advantages are high curative effect, low by-effect and low cost.

Description

technical field [0001] The invention relates to a preparation method of medicines for treating various nephritis, nephropathy and renal failure. technical background [0002] The late stage of chronic renal failure (CRF) manifests as uremia, which is a common end-stage renal disease. It occurs on the basis of various chronic renal parenchymal lesions, and renal function declines slowly until failure. The clinical features are nausea, vomiting, fatigue, edema, water and electrolyte disturbance, metabolic acidosis, late stage can cause complete renal failure, severe anemia, severe infection, heart failure and other complications leading to death. And acute renal failure is that the glomerular filtration rate drops sharply in a short period of time, and the creatinine clearance rate can drop below 50% of the normal level in a short period of time. . There are 100-150 cases per million people per year. The above-mentioned acute renal failure and chronic renal failure are cons...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61P13/12
Inventor 王保健王吉光王建红王建峰
Owner 王保健
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products